Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Stem Cells Transplant Institute is a leading healthcare provider based in Costa Rica that specializes in advanced stem cell therapies for a wide range of medical conditions. The institute primarily utilizes human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and adipose-derived stem cells to treat inflammatory, autoimmune, and degenerative diseases. Their clinical focus includes orthopedics, neurology, and metabolic disorders, offering patients access to regenerative medicine treatments that may not be available in other jurisdictions. The facility operates under strict international standards and is led by experienced medical professionals dedicated to improving patient quality of life through cellular innovation. By combining state-of-the-art technology with personalized care, the institute has established itself as a destination for medical tourism in the regenerative medicine sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cells Transplant Institute.